Primary tabs

Search
Limit to
Export 215 results:
Filters: Author is M. Arbyn
2023
Acceptability to Healthcare Professionals of Home-Based HPV Self-Sampling for Cervical Screening: A French Qualitative Study Conducted in an Area with Low Access to Health Services, Le Goff, Johane, Le Duc-Banasz Anne-Sophie, Lefeuvre Caroline, Pivert Adeline, Ducancelle Alexandra, De Pauw H, Arbyn M., Vinay Aubeline, and Rexand-Galais Franck , Cancers, Jan-11-2023, Volume 15, Issue 21, (2023)
Accuracy of HPV E6/E7 oncoprotein tests to detect high-grade cervical lesions: a systematic literature review and meta-analysis., Downham, Laura, Jaafar Iman, Rol Mary Luz, Nyaga Victoria N., Valls Joan, Baena Armando, Li Zhang, Gunter Marc J., Arbyn M., and Almonte Maribel , Br J Cancer, 2023 Nov 16, (2023)
Assessment of the clinical and analytical performance of the Aptima SARS-CoV-2 assay using the VALCOR protocol., Dhillon, Sharon, Simoens Cindy, Cuypers Lize, Bode Jannes, Bonde Jesper, Corbisier Philippe, Cocuzza Clementina E., Van Ranst Marc, and Arbyn M. , Virol J, 2023 Feb 24, Volume 20, Issue 1, (2023)
Benefits and harms of cervical screening, triage and treatment strategies in women living with HIV., Hall, Michaela T., Simms Kate T., Murray John M., Keane Adam, Nguyen Diep T. N., Caruana Michael, Lui Gigi, Kelly Helen, Eckert Linda O., Santesso Nancy, et al. , Nat Med, 2023 Dec, Volume 29, Issue 12, (2023)
Benefits, harms and cost-effectiveness of cervical screening, triage and treatment strategies for women in the general population., Simms, Kate T., Keane Adam, Ngoc Nguyen, Diep Thi, Caruana Michael, Hall Michaela T., Lui Gigi, Gauvreau Cindy, Demke Owen, Arbyn M., Basu Partha, et al. , Nat Med, 2023 Dec, Volume 29, Issue 12, (2023)
Can REALQUALITY RQ-HPV screen be considered as a clinically validated HPV test for use in cervical cancer screening?, Arbyn, M., Cuschieri Kate, Poljak Mario, and Bonde Jesper , Clin Microbiol Infect, 2023 Dec, Volume 29, Issue 12, (2023)
Chapter 10: HPV testing on cervical cancer specimens: which assay can be used in cervical cancer screening., Arbyn, M., Rousta P., Dhillon Sharon, Gultekin M., and Cuschieri K. , ESGO Textbook of Gynaecological Oncology, Number 120, (2023)
Clinical Accuracy of Alinity m HR HPV Assay on Self- versus Clinician-Taken Samples Using the VALHUDES Protocol., Latsuzbaia, Ardashel, Van Keer Severien, Broeck Davy Vanden, Weyers Steven, Donders Gilbert, De Sutter Philippe, Tjalma Wiebren, Doyen Jean, Vorsters Alex, and Arbyn M. , J Mol Diagn, 2023 Dec, Volume 25, Issue 12, (2023)
Comparison and validation of metadta for meta-analysis of diagnostic test accuracy studies., Nyaga, Victoria N., and Arbyn M. , Res Synth Methods, 2023 May, Volume 14, Issue 3, (2023)
Comparison of the Clinical Accuracy of Xpert HPV Assay on Vaginal Self-Samples and Cervical Clinician-Taken Samples within the VALHUDES Framework., Latsuzbaia, Ardashel, Broeck Davy Vanden, Van Keer Severien, Weyers Steven, Donders Gilbert, Doyen Jean, Tjalma Wiebren, De Sutter Philippe, Vorsters Alex, and Arbyn M. , J Mol Diagn, 2023 Sep, Volume 25, Issue 9, (2023)
ESGO Prevention Committee opinion: is a single dose of HPV vaccine good enough?, Kamani, Mustafa Onur, Kyrgiou Maria, Joura Elmar, Zapardiel Ignacio, Grigore Mihaela, Arbyn M., Preti Mario, Planchamp François, and Gultekin Murat , Int J Gynecol Cancer, 2023 Apr 03, Volume 33, Issue 4, (2023)
Evaluation of the clinical performance of OncoPredict HPV® SCR assay within the VALGENT‐2 framework, Dhillon, Sharon, Cocuzza Clementina E., Pui Yan Chung Jenny, Martinelli Marianna, Giubbi Chiara, Njoku Ruth C., Bhatia Ramya, Cuschieri Kate, and Arbyn M. , Journal of Medical Virology, Jan-01-2023, Volume 95, Issue 1, (2023)
Evaluation of the clinical performance of OncoPredict HPV® SCR assay within the VALGENT-2 framework., Dhillon, Sharon, Cocuzza Clementina E., Chung Pui Yan Jen, Martinelli Marianna, Giubbi Chiara, Njoku Ruth C., Bhatia Ramya, Cuschieri Kate, and Arbyn M. , J Med Virol, 2023 Jan, Volume 95, Issue 1, (2023)
Global and regional estimates of genital human papillomavirus prevalence among men: a systematic review and meta-analysis., Bruni, Laia, Albero Ginesa, Rowley Jane, Alemany Laia, Arbyn M., Giuliano Anna R., Markowitz Lauri E., Broutet Nathalie, and Taylor Melanie , Lancet Glob Health, 2023 Sep, Volume 11, Issue 9, (2023)
Global estimates of incidence and mortality of cervical cancer in 2020: a baseline analysis of the WHO Global Cervical Cancer Elimination Initiative., Singh, Deependra, Vignat Jerome, Lorenzoni Valentina, Eslahi Marzieh, Ginsburg Ophira, Lauby-Secretan Beatrice, Arbyn M., Basu Partha, Bray Freddie, and Vaccarella Salvatore , Lancet Glob Health, 2023 Feb, Volume 11, Issue 2, (2023)
HPV testing in Polish population-based cervical cancer screening programme (HIPPO project)-study protocol of a randomised healthcare policy trial., Glinska, Patrycja, Komerska Katarzyna, Janik Beata, Olkowicz Julia, Jedrzejewska Ilona, Macios Anna, Wieszczy Paulina, Kaminski Michal F., Arbyn M., and Nowakowski Andrzej , BMC Cancer, 2023 Nov 17, Volume 23, Issue 1, (2023)
HPV-based Cervical Cancer Screening on Self-samples in the Netherlands: Challenges to Reach Women and Test Performance Questions., Arbyn, M., Costa Stefanie, Latsuzbaia Ardashel, Kellen Eliane, Girogi Rossi Paolo, Cocuzza Clementina E., Basu Partha, and Castle Philip E. , Cancer Epidemiol Biomarkers Prev, 2023 Feb 06, Volume 32, Issue 2, (2023)
Integrating human papillomavirus testing as a point-of care service using GeneXpert platforms: Findings and lessons from a Kenyan pilot study (2019-2020)., Mwenda, Valerian, Bor Joan-Paula, Nyangasi Mary, Njeru James, Olwande Sharon, Njiri Patricia, Arbyn M., Weyers Steven, Tummers Philippe, and Temmerman Marleen , PLoS One, 2023, Volume 18, Issue 5, (2023)
Intra- and interlaboratory reproducibility of the RIATOL qPCR HPV genotyping assay., Dhillon, Sharon, Chung Pui Yan Jen, Padalko Elizaveta, Praet Marleen, Pereira Ana Rita, Redzic Nina, Broeck Davy Vanden, and Arbyn M. , J Med Virol, 2023 Sep, Volume 95, Issue 9, (2023)
IPVS policy statement on HPV nucleic acid testing guidance for those utilising/considering HPV as primary precancer screening: Quality assurance and quality control issues., Garland, Suzanne M., Iftner Thomas, Cuschieri Kate, Kaufmann Andreas M., Arbyn M., de Sanjosé Silvia, Poljak Mario, Dillner Joakim, and Unger Elizabeth R. , J Clin Virol, 2023 Feb, Volume 159, (2023)
Papilloplex HR-HPV test has non-inferior clinical performance for detection of human papillomavirus infection: assessment using the VALGENT framework., Bhatia, Ramya, Alcaniz Boada Elia, Hansen Bonde, Jesper, Quint Wim G. V., Lan Xu, Moller Ejegod, Ditte, Cuschieri Kate, and Arbyn M. , J Clin Pathol, March 2023 , Volume 76, Issue 3, (2023)

QR code

QR code for this page URL